A review on the use of Lumateperone in the treatment of Schizophrenia

Abstract

Schizophrenia is a typical, possibly extreme psychotic problem found in patients around the world. It is an ongoing disease influencing roughly one percent of the general population. Consistently, approximately 1 out of 10,000 is determined to have this problem. While positive symptoms of schizophrenia, such as delusions and hallucinations, are frequently improved by modern antipsychotic therapy, their effectiveness in treating negative symptoms, cognitive symtoms and social functioning is limited. A new antipsychotic that has been approved by the Food and Drug Administration (FDA) which has been ensured to provide to adults suffering from schizophrenia. Diminishing both the positive and negative side effects of schizophrenia, it has become a promising treatment option. Compared to other treatments like risperidone, lumateperone has demonstrated effectiveness in reducing symptoms. Overall, lumateperone is a safe and well-tolerated treatment for a wide range of patients.